ANGPT2 and myalgic encephalomeyelitis/chronic fatigue syndrome: With increased levels of ET-1 in both patient groups, the finding of decreased Ang-2 levels exclusively in PCS could provide a starting point for differentiation between PCS and ME/CFS in terms of biomarker profiles.